David Sinclair is a professor of genetics at Harvard Medical School and one of the most prominent and polarizing figures in longevity science. Co-discoverer of sirtuins as aging regulators and a prolific author of influential papers, he has also become a public intellectual arguing that aging is a disease — one that may be treatable within our lifetimes.
## The Information Theory of Aging
Sinclair’s central hypothesis is that aging is caused not primarily by the accumulation of DNA mutations, but by the loss of epigenetic information — the patterns of DNA methylation and histone modification that control which genes are expressed in each cell.
He uses the analogy of a scratched CD: the music (DNA) is intact, but the mechanism that reads it (the epigenetic program) has become corrupted. If you could restore the original reading program, the cell would function as it did when young.
The experimental support for this view is striking. In a 2020 Nature paper, Sinclair’s lab delivered three Yamanaka transcription factors (Oct4, Sox2, Klf4) to retinal neurons in aged mice using gene therapy. The treated neurons showed rejuvenated gene expression profiles and partially restored vision in mice with optic nerve damage. See the [original paper](https://www.nature.com/articles/s41586-020-2975-4).
In 2023, a Cell paper from the Sinclair lab took this further: inducing epigenetic aging in mice using a genetic switch caused rapid development of aging phenotypes across multiple tissues. Removing the inducing signal partially reversed the phenotypes — providing direct causal evidence that epigenetic changes drive aging, not just correlate with it.
## Scientific Controversy
Sinclair’s theory and style have generated sustained debate within the field.
**On the theory**: Most aging researchers accept that epigenetic changes are a significant driver of aging, but dispute whether they are the primary cause. Other hallmarks — genomic instability, proteostasis failure, mitochondrial dysfunction — appear independently important, not merely downstream of epigenetic drift. The claim that a single unified mechanism underlies aging remains contested.
**On scientific conduct**: Sinclair has publicly disclosed his personal supplement regimen (NMN, NR, resveratrol, metformin), which critics argue blurs the line between researcher and advocate. In 2023, Science journalists raised questions about image handling in some lab publications; subsequent investigation did not find evidence of misconduct, but the episode affected his reputation within the field.
## Partial Cellular Reprogramming
The most exciting potential application of the information theory is partial reprogramming: using Yamanaka factors (Oct4, Sox2, Klf4, c-Myc) to reset the epigenetic state of adult cells to a younger configuration without fully dedifferentiating them into pluripotent stem cells.
Multiple companies are pursuing this approach: Altos Labs (backed by Jeff Bezos, valuation exceeding $3 billion), Retro Biosciences, and Rejuvenate Bio. The central engineering challenge is achieving controlled rejuvenation in vivo without triggering tumor formation or loss of cell identity.
This remains early-stage science. But if partial reprogramming works safely in humans, it would represent the most direct implementation of Sinclair’s theory — and potentially the most significant advance in medicine in decades. For context, see [Longevity Clinics](https://sunqi.org/longevity-clinics-global-en/) and [Senolytics](https://sunqi.org/senolytics-anti-aging-en/).
—
